Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab

Neurology

Volumn 80, Issue 19, 2013, Pages 1812-1813

  Yeung, Jennifer ^a   Cauquil, Cécile ^a   Saliou, Guillaume ^a   Nasser, Ghaida ^a   Rostomashvili, Sophio ^a   Adams, David ^a,b   Théaudin, Marie ^a,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b BICÊTRE HOSPITAL   (France)

^c Universite Paris Sud   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; METHYLPREDNISOLONE; NATALIZUMAB; VALACICLOVIR;

ADULT; CASE REPORT; FEMALE; HUMAN; MULTIPLE SCLEROSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHORT SURVEY; SPINAL CORD; VARICELLA ZOSTER VIRUS;

ACUTE DISEASE; ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELITIS;

EID: 84879082586     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182918d27     Document Type: Short Survey

References (5)

1. Seiguer Shenoy E, Mylonakis E, Hurtado RM, Venna N. Natalizumab and HSV meningitis. J Neurovirol 2011;17:288-290.
2. Kwiatkowski A, Gallois J, Bilbault N, Calais G, Mackowiak A, Hautecoeur P. Herpes encephalitis during natalizumab treatment in multiple sclerosis. Mult Scler 2012;18:909-911.
3. Keystone EC, Kavanaugh AF, Sharp JT, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebocontrolled, 52-week trial. Arthritis Rheum 2004;50:1400-1410.
4. Buccoliero G, Loreno G, Romanelli C, Looperfido P, Resta F. Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor a agent in a psoriatic arthritis patient. New Microb 2010;33:271-274.
5. Vickrey E, Allen S, Mehta J, Singhal S. Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy. Cancer 2009;115:229-232.